Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02962050 · ClinicalTrials.gov registry record
Delineating Swallowing Impairment and Decline in ALS
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 109
- Enrollment target
NCT02962050 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 109 participants.
The verdict
NCT02962050 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
Study Summary
The purpose of this study is to 1) evaluate the discriminant ability of simple clinical markers to detect swallowing impairment in individuals with ALS, 2) develop and validate a minimally invasive clinical screening tool for use at multidisciplinary ALS clinics, and 3) determine the natural history of swallowing impairment and decline in ALS.
Interventions
- PROCEDURE Videofluoroscopic Swallowing Study (VFSS)
- DEVICE Voluntary Peak Cough Flow Testing
- DEVICE Iowa Oral Performance Instrument
- DRUG Capsaicin Challenge
- DEVICE Pulmonary Function Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2017-05-31 |
| Est. Completion | 2023-02-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02962050
The ClinicalTrials.gov registry entry for NCT02962050 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Videofluoroscopic Swallowing Study (VFSS) is the first listed.
NCT02962050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02962050 about?
NCT02962050 is a clinical study titled "Delineating Swallowing Impairment and Decline in ALS". The purpose of this study is to 1) evaluate the discriminant ability of simple clinical markers to detect swallowing impairment in individuals with ALS, 2) develop and validate a minimally invasive clinical screening tool for use at multidisciplinary ALS clinics, and 3) determine the natural history...
What is the current status of trial NCT02962050?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2017-05-31. Estimated completion is 2023-02-16.
What interventions are being tested in trial NCT02962050?
The interventions under investigation include: Videofluoroscopic Swallowing Study (VFSS) (PROCEDURE), Voluntary Peak Cough Flow Testing (DEVICE), Iowa Oral Performance Instrument (DEVICE), Capsaicin Challenge (DRUG), Pulmonary Function Testing (DEVICE).
Who is sponsoring clinical trial NCT02962050?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.